Comparative Relative Lung Bioavailability of HFA-Seretide via spacer devices in healthy volunteers

Registry ID

EUCTR2007-003627-20

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

University of Dundee, Research & Innovation Services

Start date

2009-01-28

Completion date

2009-12-30

Last update

2026-08-16

Conditions

• Bronchial Asthma

Summary

1. To establish whether, the systemic bioavailability of inhaled Seretide® HFA formulation is comparable via the pMDI, Volumatic®, Aerochamber™ Plus and Synchro-breathe devices

Locations

• , , UK

Related clinical trials

• Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
• N95 Masks for Lung Health While Golfing During Wildfire Season
• Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
• Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
• Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
• Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

View on source registry